Mubadala Investment Co PJSC has reported changes in its investment portfolio, including acquiring stakes in Pfizer and AbbVie. Concurrently, the company has divested its holdings in Merck and Dell. This strategic shift indicates a reallocation of investment focus within the pharmaceutical and technology sectors.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell
Mubadala Investment Co PJSC has reported changes in its investment portfolio, including acquiring stakes in Pfizer and AbbVie. Concurrently, the company has divested its holdings in Merck and Dell. This strategic shift indicates a reallocation of investment focus within the pharmaceutical and technology sectors.